Cary Street Partners Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $886K | Buy |
8,207
+958
| +13% | +$103K | 0.12% | 122 |
|
|
2024
Q2 | $787K | Hold |
7,249
| – | – | 0.12% | 125 |
|
|
2024
Q1 | $957K | Buy |
7,249
+214
| +3% | +$28.2K | 0.15% | 111 |
|
|
2023
Q4 | $856K | Sell |
7,035
-255
| -3% | -$31K | 0.15% | 111 |
|
|
2023
Q3 | $818K | Buy |
7,290
+958
| +15% | +$108K | 0.15% | 112 |
|
|
2023
Q2 | $922K | Sell |
6,332
-55
| -0.9% | -$8.01K | 0.17% | 106 |
|
|
2023
Q1 | $825K | Sell |
6,387
-490
| -7% | -$63.3K | 0.16% | 106 |
|
|
2022
Q4 | $877K | Sell |
6,877
-485
| -7% | -$61.8K | 0.18% | 108 |
|
|
2022
Q3 | $770K | Buy |
7,362
+625
| +9% | +$65.4K | 0.18% | 101 |
|
|
2022
Q2 | $708K | Sell |
6,737
-105
| -2% | -$11K | 0.17% | 105 |
|
|
2022
Q1 | $875K | Sell |
6,842
-267
| -4% | -$34.1K | 0.17% | 110 |
|
|
2021
Q4 | $877K | Buy |
7,109
+1,058
| +17% | +$131K | 0.19% | 114 |
|
|
2021
Q3 | $860K | Sell |
6,051
-189
| -3% | -$26.9K | 0.3% | 90 |
|
|
2021
Q2 | $975K | Sell |
6,240
-69,330
| -92% | -$10.8M | 0.23% | 96 |
|
|
2021
Q1 | $981K | Buy |
75,570
+6,539
| +9% | +$84.9K | 0.24% | 94 |
|
|
2020
Q4 | $891K | Buy |
+69,031
| New | +$891K | 0.26% | 86 |
|